Calif. Board of Pharmacy looks to restrict access to B-12 formulation
The California Board of Pharmacy is looking to restrict access to Category 1 sterile compounds like B-12 shots and glutathione. They're elements that many people with health issues - including Lyme disease, diabetes, and chronic fatigue syndrome - depend on. Many firefighters say these glutathione treatments help them recover after battling wildfires. After significant public backlash, the board is looking to restrict access and require authorization patient by patient.
Top Videos
Calif. Board of Pharmacy looks to restrict access to B-12 formulation
Car plows into Glendale building
Brandon Clarke's cause of death revealed: TMZ
Stephen Cloobeck to enter plea for alleged witness tampering
Road rage probe leads CHP to 20,000 rounds of ammunition, 20 illegal firearms in Yucaipa
Huntington Hospital bomb threat in Pasadena
Perez Hilton's family releases statement
Trump: Deal to open Strait of Hormuz 'could be' done soon
How to hit the road with free gas this weekend
Man living inside billboard as part of Netflix movie promotion for "The Last House"
Campaign to clear out abandoned cars in South LA
Ridge Fire burning in LA, Kern counties
Family of late community activist in South LA speaks out
Car into Temple Sinai in Glendale; 8 injured
Historic Bruin Theater to reopen
Stephen Cloobeck to enter plea to alleged witness tampering
LA community activist shot dead in Hyde Park
LA DA: Cracking down on hate crimes a top priority
Air quality officials approve abatement order vs. Lineage
Trump signs birthright citizenship executive order
"Puppy" killed by coyote in Palos Verdes Estates
Measles warning at Universal Studios Hollywood
Hollywood Hills water main break
Suspect leads multiple-county car chase
Police chase suspect stops to fill gas mid-pursuit
